Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05232682 · ClinicalTrials.gov registry record · Phase 2
Probiotics, Immune Function, and the Brain in Alcohol Consumers
A Phase 2 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT05232682 is a Phase 2 study that has completed, run by Brown University. The registered enrollment target is 32 participants.
The verdict
NCT05232682, a Phase 2 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
This pilot project is a brief, open-label clinical trial of probiotics as an intervention in heavy drinkers. Heavy drinkers who do not yet show significant signs of liver disease may stand to benefit from probiotics, but no clinical trials to date have addressed this population. This study will recruit heavy drinkers to complete an open-label within-subjects trial. The study will investigate effects of probiotics on specific biomarkers in healthy heavy drinkers who currently are not seeking to change their alcohol use (i.e., are non-treatment-seeking).
Interventions
- DIETARY_SUPPLEMENT Seed DS-01 Daily Synbiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-02-24 |
| Est. Completion | 2023-08-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05232682
The ClinicalTrials.gov registry entry for NCT05232682 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Seed DS-01 Daily Synbiotic is the first listed.
NCT05232682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05232682 about?
NCT05232682 is a clinical study titled "Probiotics, Immune Function, and the Brain in Alcohol Consumers". This pilot project is a brief, open-label clinical trial of probiotics as an intervention in heavy drinkers. Heavy drinkers who do not yet show significant signs of liver disease may stand to benefit from probiotics, but no clinical trials to date have addressed this population. This study will recr...
What is the current status of trial NCT05232682?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2022-02-24. Estimated completion is 2023-08-09.
What interventions are being tested in trial NCT05232682?
The interventions under investigation include: Seed DS-01 Daily Synbiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05232682?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.